Issues of cost-effectiveness in the use of antithrombotic therapy for ischemic heart disease
Am Heart J
.
1997 Nov;134(5 Pt 2):S88-96.
Authors
R M Califf
1
,
D B Mark
Affiliation
1
Department of Medicine, Duke University Medical Center, Durham, N.C., USA.
PMID:
9396640
No abstract available
Publication types
Research Support, Non-U.S. Gov't
Review
MeSH terms
Cost-Benefit Analysis
Drug Costs
Fibrinolytic Agents / economics*
Fibrinolytic Agents / therapeutic use*
Humans
Myocardial Ischemia / drug therapy*
Substances
Fibrinolytic Agents